March 7, 2024
Sysmex Corporation
Announcement of Organizational and Personnel Changes
Sysmex Corporation (HQ: Kobe, Japan; President: Kaoru Asano) announces today its decision to implement organizational and personnel changes, effective April 1, 2024, as detailed below.
1. Organizational Changes
- Creating new value for existing products
- The Production Design Center will be newly established to reinforce the renewal design function (quality improvement, supply continuity, and product value maintenance), thereby promoting to maintain and reinforce the added value of existing instruments in the market.
- Reinforcing clinical and scientific research activities
- Under the Medical & Scientific Affairs, the role of the Medical Affairs 3 will be transferred to the Medical Affairs 1 to reinforce collaboration between the two fields. In contrast, the role of the Scientific Affairs will be divided into the Scientific Affairs 1, which is responsible for scientific PR and planning and promotion of scientific seminars, and the Scientific Affairs 2, which handle planning and promotion of scientific research and precision assurance, to reinforce specialized knowledge and accelerate the speed of implementation.
- Reinforcing the MR Business
- The MR Business will establish the MR Business Development to plan and promote the MR business, and the MR Market Development to handle sales and services, to further reinforce the MR business and expand the market.
- Promote efficiency in reagent production
- The Manufacturing System will be newly established in the Reagent Production to provide manufacturing technology support to global reagent production factories and promote digitalization, thereby reinforcing the efficiency of reagent production through innovation and digitalization of manufacturing technology.
2. Personnel Changes and Appointments
- Appointment of Senior Executive Officer (Promotion)
Name | New Position | Current Position |
Mitsuhisa Kanagawa | Senior Executive Officer | Executive Officer |
(2) Appointment of Executive Officer (Newly Appointed) | ||
Name | New Position | Current Position |
Kenji Tsujimoto | Executive Officer | Executive Vice President of |
Next Generation Medical | ||
Business Development | ||
(3) Retirement of Executive Officer (Completion of Contract Term) | ||
Name | New Position | Current Position |
Mamoru Kubota | - | Senior Executive Officer |
(4) Changes in Operating and Functional Changes of Executive Officers | ||
Name | New Position | Current Position |
Kensuke Iizuka | Senior Executive Officer | Senior Executive Officer |
In charge of Corporate Strategy, | In charge of Corporate Strategy | |
Human Resources, and | Executive Vice President of | |
Next Generation Medical | Corporate Business Planning | |
Business Development | Div., Corporate Executive Office | |
Executive Vice President of | ||
Corporate Business Planning Div. | ||
Mitsuhisa Kanagawa | Senior Executive Officer | Executive Officer |
In charge of Instrument | In charge of Instrument | |
Production and SCM | Production and SCM | |
Takaaki Nagai | Executive Officer | Executive Officer |
Deputy in charge of | Executive Vice President of | |
Instrument Production and SCM | System Engineering Div. | |
Executive Vice President of | ||
Production Design Center | ||
Kenji Tsujimoto | Executive Officer | Executive Vice President of Next |
Executive Vice President of Next | Generation Medical Business | |
Generation Medical Business | Development Div. | |
Development Div. |
The information contained in this press release is current as of the date of the announcement but may be subject to change without prior notice.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Sysmex Corporation published this content on 07 March 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 07 March 2024 06:05:38 UTC.